PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN - A NOVEL TOPOISOMERASE-I INHIBITOR

被引：346

作者：

ROWINSKY, EK

GROCHOW, LB

HENDRICKS, CB

ETTINGER, DS

FORASTIERE, AA

HUROWITZ, LA

MCGUIRE, WP

SARTORIUS, SE

LUBEJKO, BG

KAUFMANN, SH

DONEHOWER, RC

机构：

来源：

关键词：

D O I：

10.1200/JCO.1992.10.4.647

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：647 / 656

页数：10

共 32 条

[1] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE NEW ANTITUMOR DRUG SK-AND-F 104864-A (NSC 609699) IN PLASMA
BEIJNEN, JH
SMITH, BR
KEIJER, WJ
VANGIJN, R
HUININK, WWT
VLASVELD, LT
RODENHUIS, S
UNDERBERG, WJM
[J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) : 789 - 794
[2] CREAVEN PJ, 1972, CANCER CHEMOTH REP 1, V56, P573
[3] TOPOISOMERASE-TARGETING ANTITUMOR DRUGS
DARPA, P
LIU, LF
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) : 163 - 177
[4] DNA TOPOISOMERASES FROM RAT-LIVER - PHYSIOLOGICAL VARIATIONS
DUGUET, M
LAVENOT, C
HARPER, F
MIRAMBEAU, G
DERECONDO, AM
[J]. NUCLEIC ACIDS RESEARCH, 1983, 11 (04) : 1059 - 1075
[5] ENG WK, 1988, MOL PHARMACOL, V34, P755
[6] DNA TOPOISOMERASE-I TARGETED CHEMOTHERAPY OF HUMAN-COLON CANCER IN XENOGRAFTS
GIOVANELLA, BC
STEHLIN, JS
WALL, ME
WANI, MC
NICHOLAS, AW
LIU, LF
SILBER, R
POTMESIL, M
[J]. SCIENCE, 1989, 246 (4933) : 1046 - 1048
[7] GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI, P83
[8] EXPRESSION OF A MULTIDRUG RESISTANCE GENE IN HUMAN CANCERS
GOLDSTEIN, LJ
GALSKI, H
FOJO, A
WILLINGHAM, M
LAI, SL
GAZDAR, A
PIRKER, R
GREEN, A
CRIST, W
BRODEUR, GM
LIEBER, M
COSSMAN, J
GOTTESMAN, MM
PASTAN, I
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02) : 116 - 124
[9] GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461
[10] GOTTLIEB JA, 1972, CANCER CHEMOTH REP 1, V56, P103